Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 140.00
Bid: 140.00
Ask: 141.20
Change: -0.60 (-0.43%)
Spread: 1.20 (0.857%)
Open: 144.00
High: 144.00
Low: 140.00
Prev. Close: 140.60
ELM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Statement

30 Apr 2019 07:00

RNS Number : 4715X
Elementis PLC
30 April 2019
 

Elementis plc

AGM Trading Statement

Market conditions remain challenging, particularly in Coatings

On track to deliver further progress in 2019 led by self-help initiatives

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues a trading update for the three months ended 31 March 2019.

Reflecting broader macroeconomic trends, global market conditions remain challenging, particularly in Coatings. Elementis anticipates further progress in 2019, albeit slightly below expectations. Some improvement in the demand environment and further cost efficiencies in-train are expected to result in a stronger second half performance.

The Group remains focused on delivering its plans to integrate the Talc business, transform Coatings and grow Personal Care. This strategy, supported by self-help measures focused on cost efficiency and cash delivery will provide a robust financial platform to deliver future growth and shareholder value creation.

Business performance

· Personal Care had a solid first quarter with strong growth in cosmetics offset by a weaker start in anti-perspirant active ingredients. Bentone HydroclayTM, our new hectorite-based ingredient focused on the skin care market, launched in the quarter and is building encouraging customer momentum.

 

· In Coatings, whilst price/mix improved, weak demand and some de-stocking, particularly in Asia, caused revenue to decline versus the strong prior year period. Early benefits of the transformation programme helped to partially mitigate the profit impact and the programme continues to progress at pace.

 

· Integration of the Talc business remains on track for completion by October 2019 with a focus on delivering $2m of identified cost synergies and new business opportunities. Against strong comparatives, the business saw robust performance across most of its industrial talc applications but weaker demand from paper and automotive markets.

 

· Energy had a steady start to the year with industry infrastructure constraints in North America anticipated to ease in H2.

 

· Chromium sales grew on the prior year period with improved pricing offsetting lower demand levels.

 

Commenting on the performance, CEO, Paul Waterman said,

"Whilst trading conditions in the first quarter of 2019 have proved challenging, Elementis remains focused on delivery, improving returns and deleveraging. This will be underpinned by the integration of the Talc business, delivery of self-help efficiency measures and an unrelenting focus on cash generation."

 

Enquiries

Elementis plc

James Curran, Investor Relations Tel: 020 7067 2994

 

Tulchan

Martin Robinson Tel: 020 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFFTSVIAFIA
Date   Source Headline
28th Jun 201312:42 pmRNSTotal Voting Rights
3rd Jun 201312:00 pmRNSTotal Voting Rights
22nd May 201311:00 amRNSAdditional Listing
7th May 20131:00 pmRNSDirector/PDMR Shareholding
7th May 20137:00 amRNSDirectorate Change
30th Apr 201311:00 amRNSTotal Voting Rights
25th Apr 20133:12 pmRNSResult of AGM
25th Apr 20137:00 amRNSAGM Statement
12th Apr 201311:00 amRNSDirector/PDMR Shareholding
3rd Apr 20134:10 pmRNSDirector/PDMR Shareholding
28th Mar 201311:30 amRNSTotal Voting Rights
25th Mar 201311:00 amRNSHolding(s) in Company
21st Mar 20139:30 amRNS2012 Annual Financial Report & Notice of 2013 AGM
6th Mar 201311:00 amRNSHolding(s) in Company
6th Mar 201311:00 amRNSHolding(s) in Company
6th Mar 201311:00 amRNSAdditional Listing
1st Mar 201311:00 amRNSBlocklisting Interim Review
28th Feb 201311:00 amRNSTotal Voting Rights
26th Feb 20137:00 amRNSFinal Results
25th Feb 201311:00 amRNSHolding(s) in Company
20th Feb 20137:00 amRNSAcquisition
8th Feb 201311:00 amRNSDirector Declaration
1st Feb 201311:00 amRNSDirector/PDMR Shareholding
31st Jan 201311:00 amRNSTotal Voting Rights
24th Jan 201311:00 amRNSHolding(s) in Company
24th Jan 201311:00 amRNSHolding(s) in Company
17th Jan 201311:00 amRNSDirector/PDMR Shareholding
2nd Jan 201311:00 amRNSTotal Voting Rights
30th Nov 201211:00 amRNSTotal Voting Rights
7th Nov 201211:00 amRNSAdditional Listing
31st Oct 20121:00 pmRNSTotal Voting Rights
26th Oct 20127:00 amRNSInterim Management Statement
3rd Oct 201211:00 amRNSAdditional Listing
1st Oct 20127:00 amRNSElementis announces completion of its acquisition
28th Sep 20121:00 pmRNSTotal Voting Rights
24th Sep 201211:19 amRNSElementis expands manufacturing in N America
13th Sep 20125:08 pmRNSHolding(s) in Company
12th Sep 20129:57 amRNSAdditional Listing
10th Sep 20122:00 pmRNSDirector/PDMR Shareholding
31st Aug 20122:00 pmRNSDirector/PDMR Shareholding
31st Aug 20121:00 pmRNSTotal Voting Rights
15th Aug 20124:15 pmRNSHolding(s) in Company
10th Aug 201211:15 amRNSHolding(s) in Company
8th Aug 20123:00 pmRNSDirector/PDMR Shareholding
7th Aug 20121:57 pmRNSHolding(s) in Company
1st Aug 201211:00 amRNSAdditional Listing
31st Jul 20123:00 pmRNSBlocklisting Interim Review
31st Jul 20121:00 pmRNSTotal Voting Rights
31st Jul 20127:00 amRNSInterim Results
29th Jun 20124:53 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.